ingenious has partnered with Columbia University, and is the exclusive provider of the F.A.S.T.™ system. This biotechnology system is an innovative new method of gene targeting, where up to five distinct mouse lines can be generated with only one targeting event including: global gene knockout, tissue/time-specific gene rescue, ectopic gene expression, inducible/reversible gene overexpression, and inducible/reversible gene knockdown.
Our partnership with Gene Bridges provides clients access to cutting edge recombineering technology. Recombineering with Red/ET allows cloning, subcloning and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs. Red/ET Recombination also increases the power of CRISPR/Cas9 to extend genome studies.
ingenious’ partnership with TET systems provides clients with highly flexible options when designing their mouse model. The Tet Technology provides efficient, precise and reversible control over both timing and level of gene expression in eukaryotic cells. Its specificity, chemical and physiological properties of the inducing agents have made the Tet System the most widely applied inducible gene expression system. The usage of the Tet Technology is demonstrated by more than 10,000 publications. Besides facilitating physiological studies at the cellular level, the Tet System also permits detailed analyses of complex biological processes.
With locations in Tokyo, Cosmo Bio provides major research organizations and institutions of Japan with our custom services. Cosmo Bio has been supporting and inspiring the Japan life science research community for over 30 years and is proud to be recognized as one of Japan’s leading suppliers. Cosmo Bio provides our most up-to-date products and technical information to laboratories, research institutes, life-science education and testing organizations throughout Japan.
We have partnered with Stony Brook University, an internationally recognized research institution, for over 10 years to bring our clients leading technologies and services in biotechnology.
ingenious has a strong working relationship with Charles River Laboratories, Inc. bringing our clients the most specialized, high quality animal health standards available.
We have a long-standing working relationship with Umea University, which was solidified through the signing of a Master Institute Service Agreement for making mouse models.
Our long standing working relationship with Massachusetts General Hospital was solidified through the signing of a Master Service Agreement for mouse model production.
We are a proud partner and supporter of the Center for Biotechnology. The Center strives to catalyze the translation of basic biomedical sciences into diagnostic and therapeutic technologies that benefit human health and society, and fuel economic growth. Through groundbreaking initiatives, together we support the advancement of biomedical innovation by helping to bridge the gap between discovery and commercial success and by training the next generation of biomedical leaders.
ingenious is a proud member and supporter of The New York Biotechnology Association (NYBA), the nonprofit trade association dedicated to the development and growth of the biotechnology industry in New York. Together we are dedicated to advancing life science research and commercialization. The New York area is the largest and richest bioscience community in the world, boasting over 60% of Big Pharma national or global headquarters, supporting more than 75,000 biotechnology jobs, graduating more life science PhDs than any other region in the US, and houses the largest concentration of academic medical centers worldwide.